FULGENT GENETICS, INC. Number of Reportable Segments
FULGENT GENETICS, INC. (FLGT) reported Number of Reportable Segments of 2 Segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-07-30
- FULGENT GENETICS, INC. number of reportable segments for the quarter ending 2026-03-31 was 2.00 Segment, a 0.00% change year-over-year.
- FULGENT GENETICS, INC. number of reportable segments for the quarter ending 2025-03-31 was 2.00 Segment, a 0.00% change year-over-year.
- FULGENT GENETICS, INC. number of reportable segments for the quarter ending 2024-03-31 was 2.00 Segment, a 100.00% increase year-over-year.
- FULGENT GENETICS, INC. number of reportable segments for the quarter ending 2023-03-31 was 1.00 Segment, a 0.00% change year-over-year.
- FULGENT GENETICS, INC. number of reportable segments for fiscal 2025 was 2.00 Segment, a 0.00% change from fiscal 2024.
- FULGENT GENETICS, INC. number of reportable segments for fiscal 2024 was 2.00 Segment.
- FULGENT GENETICS, INC. number of reportable segments for fiscal 2022 was 1.00 Segment, a 0.00% change from fiscal 2021.
- FULGENT GENETICS, INC. number of reportable segments for fiscal 2021 was 1.00 Segment, a 0.00% change from fiscal 2020.
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month | Number of Reportable Segments 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 2.00 Segment 10-Q · filed 2026-07-30 | ||||
| 2026-03-31 | 2.00 Segment 10-Q · filed 2026-05-01 | ||||
| 2025-12-31 | 2.00 Segment 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | 2.00 Segment 10-Q · filed 2025-11-07 | ||||
| 2025-06-30 | 2.00 Segment 10-Q · filed 2025-08-01 | ||||
| 2025-03-31 | 2.00 Segment 10-Q · filed 2025-05-02 | ||||
| 2024-12-31 | 2.00 Segment 10-K · filed 2025-02-28 | ||||
| 2024-09-30 | 2.00 Segment 10-Q · filed 2024-11-08 | ||||
| 2024-06-30 | 2.00 Segment 10-Q · filed 2024-08-02 | ||||
| 2024-03-31 | 2.00 Segment 10-Q · filed 2024-05-03 | ||||
| 2023-12-31 | 1.00 Segment 10-Q · filed 2024-11-08 | 2.00 Segment 10-K · filed 2024-02-28 | |||
| 2023-09-30 | 1.00 Segment 10-K · filed 2024-02-28 | ||||
| 2023-06-30 | 1.00 Segment 10-Q · filed 2023-08-04 | ||||
| 2023-03-31 | 1.00 Segment 10-Q · filed 2023-05-05 | ||||
| 2022-12-31 | 1.00 Segment 10-K · filed 2024-02-28 | ||||
| 2022-09-30 | 1.00 Segment 10-Q · filed 2022-11-07 | ||||
| 2022-06-30 | 1.00 Segment 10-Q · filed 2022-08-04 | ||||
| 2022-03-31 | 1.00 Segment 10-Q · filed 2022-05-05 | ||||
| 2021-12-31 | 1.00 Segment 10-K · filed 2022-02-28 | ||||
| 2021-09-30 | 1.00 Segment 10-Q · filed 2021-11-09 | ||||
| 2021-06-30 | 1.00 Segment 10-Q · filed 2021-08-10 | ||||
| 2021-03-31 | 1.00 Segment 10-Q · filed 2021-05-07 | ||||
| 2020-12-31 | 1.00 Segment 10-K · filed 2021-03-08 | ||||
| 2020-09-30 | 1.00 Segment 10-Q · filed 2020-11-09 | ||||
| 2020-06-30 | 1.00 Segment 10-Q · filed 2020-08-05 | ||||
| 2020-03-31 | 1.00 Segment 10-Q · filed 2020-05-06 | ||||
| 2019-12-31 | 1.00 Segment 10-K · filed 2020-03-13 | ||||
| 2019-09-30 | 1.00 Segment 10-Q · filed 2019-11-08 | ||||
| 2019-06-30 | 1.00 Segment 10-Q · filed 2019-08-12 | ||||
| 2019-03-31 | 1.00 Segment 10-Q · filed 2019-05-10 | ||||
| 2018-12-31 | 1.00 Segment 10-K · filed 2019-03-22 | ||||
| 2018-09-30 | 1.00 Segment 10-Q · filed 2018-11-09 | ||||
| 2018-06-30 | 1.00 Segment 10-Q · filed 2018-08-13 | ||||
| 2018-03-31 | 1.00 Segment 10-Q · filed 2018-05-14 | ||||
| 2017-12-31 | 1.00 Segment 10-K · filed 2018-03-20 | ||||
| 2017-09-30 | 1.00 Segment 10-Q · filed 2017-11-13 | ||||
| 2017-06-30 | 1.00 Segment 10-Q · filed 2017-08-14 | ||||
| 2017-03-31 | 1.00 Segment 10-Q · filed 2017-05-09 | ||||
| 2016-12-31 | 1.00 Segment 10-K · filed 2017-03-17 | ||||
| 2016-09-30 | 1.00 Segment 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |